CADIAN CAPITAL MANAGEMENT, LP - MIRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
CADIAN CAPITAL MANAGEMENT, LP ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$45,343,535
+38.6%
1,434,922
+13.4%
1.82%
+18.0%
Q2 2023$32,723,532
+85.4%
1,264,922
+72.1%
1.55%
+40.8%
Q1 2023$17,652,826
+139.9%
734,922
+94.7%
1.10%
+105.8%
Q4 2022$7,358,793
-74.3%
377,374
-72.3%
0.53%
-68.1%
Q3 2022$28,674,000
+6.3%
1,364,786
-1.5%
1.68%
-8.0%
Q2 2022$26,972,000
+64.4%
1,385,997
+86.0%
1.82%
+122.5%
Q1 2022$16,405,000745,0000.82%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,921,118$38,269,0006.42%
FRAZIER MANAGEMENT LLC 3,566,912$71,053,0005.68%
Novo Holdings A/S 2,445,147$48,707,0002.52%
Sio Capital Management, LLC 248,978$4,960,0001.58%
Mesirow Financial Investment Management, Inc. 25,795$514,0001.51%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,282,912$65,396,0001.28%
NEA Management Company, LLC 4,187,801$83,421,0000.99%
MPM BioImpact LLC 308,532$6,146,0000.95%
Rock Springs Capital Management LP 1,525,623$30,390,0000.64%
BVF INC/IL 435,936$8,684,0000.34%
View complete list of MIRUM PHARMACEUTICALS INC shareholders